| # | Title | Journal | Year | Citations |
|---|
| 1 | 2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC) | European Heart Journal | 2020 | 647 |
| 2 | Targeted Therapies for Renal Cell Carcinoma: Review of Adverse Event Management Strategies | Journal of the National Cancer Institute | 2012 | 197 |
| 3 | Regorafenib for patients with previously untreated metastatic or unresectable renal-cell carcinoma: a single-group phase 2 trial | Lancet Oncology, The | 2012 | 101 |
| 4 | Mediterranean diet adherence in the Mediterranean healthy eating, aging and lifestyle (MEAL) study cohort | International Journal of Food Sciences and Nutrition | 2018 | 79 |
| 5 | High-resolution noncontact charge-density mapping of endocardial activation | JCI Insight | 2019 | 61 |
| 6 | Whole grain, bran and cereal fibre consumption and CVD: a systematic review | British Journal of Nutrition | 2019 | 54 |
| 7 | Circulating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma | Cancer Chemotherapy and Pharmacology | 2014 | 52 |
| 8 | Effect of small angiokinase inhibitor nintedanib (BIBF 1120) on QT interval in patients with previously untreated, advanced renal cell cancer in an open-label, phase II study | Investigational New Drugs | 2013 | 48 |
| 9 | Coffee Consumption and Risk of Biliary Tract Cancers and Liver Cancer: A Dose–Response Meta-Analysis of Prospective Cohort Studies | Nutrients | 2017 | 43 |
| 10 | Deconvoluting hepatic processing of carbon nanotubes | Nature Communications | 2016 | 42 |
| 11 | Tivozanib versus sorafenib as initial targeted therapy for patients with advanced renal cell carcinoma: Results from a phase III randomized, open-label, multicenter trial. | Journal of Clinical Oncology | 2012 | 40 |
| 12 | Severe reaction to radiotherapy for breast cancer as the presenting feature of ataxia telangiectasia | British Journal of Cancer | 2012 | 36 |
| 13 | Safety and effectiveness of vinflunine in patients with metastatic transitional cell carcinoma of the urothelial tract after failure of one platinum-based systemic therapy in clinical practice | BMC Cancer | 2014 | 33 |
| 14 | Efficacy of tivozanib treatment after sorafenib in patients with advanced renal cell carcinoma: crossover of a phase 3 study | European Journal of Cancer | 2018 | 31 |
| 15 | A randomised, phase II study of nintedanib or sunitinib in previously untreated patients with advanced renal cell cancer: 3-year results | British Journal of Cancer | 2015 | 30 |
| 16 | Premature ageing of the immune system underlies immunodeficiency in ataxia telangiectasia | Clinical Immunology | 2011 | 29 |
| 17 | Metabolic profile of the Mediterranean healthy Eating, Lifestyle and Aging (MEAL) study cohort | Mediterranean Journal of Nutrition and Metabolism | 2017 | 29 |
| 18 | Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project | Annals of Oncology | 2015 | 25 |
| 19 | Update on the Integrated Nutrition Pathway for Acute Care (INPAC): post implementation tailoring and toolkit to support practice improvements | Nutrition Journal | 2018 | 23 |
| 20 | A Randomized Phase II/III Study of Naptumomab Estafenatox + IFNα versus IFNα in Renal Cell Carcinoma: Final Analysis with Baseline Biomarker Subgroup and Trend Analysis | Clinical Cancer Research | 2016 | 22 |
| 21 | More-2-Eat: evaluation protocol of a multi-site implementation of the Integrated Nutrition Pathway for Acute Care | BMC Nutrition | 2017 | 21 |
| 22 | Left Atrial Function Is Associated with Earlier Need for Cardiac Surgery in Moderate to Severe Mitral Regurgitation: Usefulness in Targeting for Early Surgery | Journal of the American Society of Echocardiography | 2018 | 19 |
| 23 | Common Variation at 1q24.1 (ALDH9A1) Is a Potential Risk Factor for Renal Cancer | PLoS ONE | 2015 | 19 |
| 24 | Evaluation of treatment options for patients with advanced renal cell carcinoma: Assessment of appropriateness, using the validated semi-quantitative RAND corporation/University of California, Los Angeles methodology | European Journal of Cancer | 2012 | 16 |
| 25 | Naptumomab Estafenatox: Targeted Immunotherapy with a Novel Immunotoxin | Current Oncology Reports | 2014 | 16 |
| 26 | Germline polymorphisms and survival of lung adenocarcinoma patients: A genome‐wide study in two European patient series | International Journal of Cancer | 2015 | 16 |
| 27 | Dietitians' Perspectives on Teaching Nutrition to Medical Students | Journal of the American College of Nutrition | 2017 | 15 |
| 28 | Overall survival results from a phase III study of tivozanib hydrochloride versus sorafenib in patients with renal cell carcinoma. | Journal of Clinical Oncology | 2013 | 15 |
| 29 | Structure, Governance, and Organizational Dynamics of University Medical Centers in the Netherlands | Academic Medicine | 2010 | 14 |
| 30 | The role of tivozanib in advanced renal cell carcinoma therapy | Expert Review of Anticancer Therapy | 2018 | 14 |
| 31 | Comparing Hospital Staff Nutrition Knowledge, Attitudes, and Practices Before and 1 Year After Improving Nutrition Care: Results From the More‐2‐Eat Implementation Project | Journal of Parenteral and Enteral Nutrition | 2018 | 12 |
| 32 | Phase II efficacy and safety study of nintedanib versus sunitinib in previously untreated renal cell carcinoma (RCC) patients. | Journal of Clinical Oncology | 2013 | 12 |
| 33 | Diagnostic accuracy of preoperative computed tomography used alone to detect lymph-node involvement at radical nephrectomy | Scandinavian Journal of Urology | 2015 | 11 |
| 34 | Pharmacometric Modeling of Liver Metastases' Diameter, Volume, and Density and Their Relation to Clinical Outcome in Imatinib‐Treated Patients With Gastrointestinal Stromal Tumors | CPT: Pharmacometrics and Systems Pharmacology | 2017 | 11 |
| 35 | Anticoagulation for Atrial Fibrillation: Is This the End of Warfarin? Not Just Yet | Journal of Angiology | 2013 | 7 |
| 36 | The association of rs1051730 genotype on adherence to and consumption of prescribed nicotine replacement therapy dose during a smoking cessation attempt | Drug and Alcohol Dependence | 2015 | 7 |
| 37 | Tivozanib in patients treatment-naive for metastatic renal cell carcinoma: A subset analysis of the phase III TIVO-1 study. | Journal of Clinical Oncology | 2013 | 7 |
| 38 | Tivozanib for the treatment of metastatic renal cancer | Expert Review of Anticancer Therapy | 2013 | 6 |
| 39 | The clinical use of granulocyte-colony stimulating factor | British Journal of Hospital Medicine (London, England: 2005) | 2014 | 6 |
| 40 | Apixaban in atrial fibrillation: does predicted risk matter? | Lancet, The | 2012 | 5 |
| 41 | Assessing the impact of evolving evidence in renal cell carcinoma treatment: An update of the Renal Cell Carcinoma Appropriateness-based Treatment Toolkit (ReCATT) | European Journal of Cancer | 2014 | 5 |
| 42 | Arrhythmia in Mitral Valve Prolapse | Journal of the American College of Cardiology | 2020 | 5 |
| 43 | Tivozanib vs sorafenib targeted therapy for advanced renal cell carcinoma: Final results of a phase III trial (901) and efficacy results of a 2nd line tivozanib extension study (902). | Journal of Clinical Oncology | 2015 | 5 |
| 44 | Setting the research agenda for health services management practice: who decides? | Evidence and Policy | 2010 | 4 |
| 45 | Benign Emptying of Postpneumonectomy Space Due to Severe Dehydration | Annals of Thoracic Surgery | 2013 | 4 |
| 46 | Cadaveric training - the solution for ultrasound-guided regional anaesthesia? | Anaesthesia | 2016 | 4 |
| 47 | A randomized phase II/III study of naptumomab estafenatox plus IFN-α versus IFN-α in advanced renal cell carcinoma. | Journal of Clinical Oncology | 2013 | 3 |
| 48 | Finding needles in a haystack: annual low-dose computed tomography screening reduces lung cancer mortality in a high-risk group | Expert Review of Anticancer Therapy | 2011 | 2 |
| 49 | Phenotypic Landscape and Risk Management in Long QT Syndrome | Journal of the American College of Cardiology | 2018 | 2 |
| 50 | Quinidine Rebooted | JACC: Clinical Electrophysiology | 2019 | 2 |
